SSG
ASMB icon

Summit Securities Group’s Assembly Biosciences ASMB Stock Holding History

Summit Securities Group’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-417
Closed -$4K – 464
2023
Q4 		$4K Buy
+417
New +$3.96K ﹤0.01% 570

Other funds holding ASMB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Summit Securities Group's ASMB Position: Q1 2024 in Review

Summit Securities Group sold out of Assembly Biosciences (ASMB) in Q1 2024, closing a stake of 417 shares — an estimated $4K sold.

Summit Securities Group first reported a position in ASMB in Q4 2023 and held it in 1 quarter. The position peaked at $4K in Q4 2023. 24 funds tracked by Wall St. Rank hold ASMB as of Q1 2024.

  • Summit Securities Group reported no remaining Assembly Biosciences position as of Q1 2024 after selling out during the quarter.
  • Summit Securities Group sold 417 Assembly Biosciences shares in Q1 2024, an estimated $4K.
  • Summit Securities Group first reported a position in Assembly Biosciences in Q4 2023 and held it in 1 quarter.
  • Summit Securities Group's Assembly Biosciences position peaked at $4K in Q4 2023.
  • 24 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2024.

Based on Summit Securities Group's 13F filing for Q1 2024, filed 13 May 2024.